Filter Results :

Your search for Immune returned 91 reports

Sort by


Aimmune Therapeutics Inc (AIMT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

31 Jan 2018  |  Published by:  GlobalData
SummaryAimmune Therapeutics Inc (Aimmune), formerly Allergen Research Corp is a clinical-stage biopharmaceutical company that develops proprietary product candidates for the treatment of peanut and other food allergies. The company's lead product candidate AR101 is used to treat the peanut allergy. ...

$ 250.00

Read More

Adaptimmune Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

31 Jan 2018  |  Published by:  GlobalData
SummaryAdaptimmune Ltd (Adaptimmune), a subsidiary of Adaptimmune Therapeutics Plc is a clinical stage biotechnology company that develops T-cell therapy products for the treatment of cancer. The company's pipeline peptides include NY-ESO TCR used to treat cancer cells, MAGE A-10 TCR used for the tr...

$ 250.00

Read More

Altimmune Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

31 Jan 2018  |  Published by:  GlobalData
SummaryAltimmune Inc (Altimmune), formerly Vaxin Inc is a biotechnology company that develops vaccines and other biological products. The company's products include novel vaccine delivery platforms, immunotherapeutic products, intranasally administered recombinant influenza vaccine, traditional infl...

$ 250.00

Read More

Adimmune Corp (4142) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

31 Jan 2018  |  Published by:  GlobalData
SummaryAdimmune Corp (Adimmune) is a biopharmaceutical supplier that manufactures vaccines, diagnostics, and biological products for various diseases. The company offers products such as Japan encephalitis vaccine, tetanus toxoid adsorbed vaccine, influenza vaccine, and ah1n1 vaccine. It also offers...

$ 250.00

Read More

Autoimmune Disease Diagnosis Market by Products (Consumables, Assay Kits, Instruments, Services), Test Type (Inflammatory Markers, Autoantibodies), Disease (RA, SLE, Thyroiditis, Scleroderma), End Users (Hospitals, Clinical Labs) - Global Forecast to 2022

29 Jan 2018  |  Published by:  MarketsandMarkets
The autoimmune disease diagnosis market projected to grow at a CAGR of 8.9% during the forecast periodThe global autoimmune disease diagnosis market is expected to reach USD 4.73 billion by 2022 from USD 3.09 billion in 2017, at a CAGR of 8.9%. Factors driving the growth of this market include the r...

$ 5,650.00

Read More

Global Human Microbiome Market (By Diseases - Cancer, Diabetes, Obesity, Acute Diarrhea or Metabolic Disorders, Autoimmune Disorders, Mental Disorders, Atopic Dermatitis and other diseases, By Technology- Cell Culture Technology, Omics Technology, High-Throughput Technology and Computational Tools, By Product - Consumables and Instruments, By End-Use - Prebiotics, Probiotics, Other Probiotic Supplements, Foods, Medical Foods, drugs and Diagnostic services) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 - 2025

01 Jan 2018  |  Published by:  Sheer Analytics & Insights
The report covers the analysis and forecast of the global human microbiome market on global as well as regional level. The study provides historic data of 2016 along with the forecast for the period between 2017 and 2025 based on revenue (US$ Million).The study provides a detailed view of the global...

$ 4,795.00

Read More

Autoimmune Disease Diagnostics Market, 2012 to 2023

07 Dec 2017  |  Published by:  Precision Business Insights
Market Outline: Autoimmune Disease Diagnostics MarketThe immune system protects the body from infections and diseases. In autoimmune disorders low or overactivity of immune system may appear. There is no exact cause of autoimmune diseases are identified. In response to unknown trigger, immune system...

$ 4,400.00

Read More

Frontier Pharma: Transplantation Therapeutics - A Highly Innovative Pipeline with a Range of Adaptive and Innate Immune-Targeting Programs Focusing on Graft-Versus-Host Disease and Kidney Transplantation

01 Dec 2017  |  Published by:  GBI Research
SummaryIn 2015 a total of 127,000 transplantations were performed worldwide, an increase of 5.8% from 2014, with 33,000 of these occurring in the EU and 32,000 in the US. Approximately 60% of these were kidney transplants, with liver, heart, lung, pancreas and small bowel transplantations accounting...

$ 6,995.00

Read More

MedImmune LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

28 Nov 2017  |  Published by:  GlobalData
SummaryMedImmune LLC (MedImmune), a subsidiary of AstraZeneca Plc, is a biotechnology company. It focuses on the research, development, manufacture and marketing of small molecules and biologics to address some of the major medical needs. The company develops therapeutic proteins, monoclonal antibod...

$ 250.00

Read More

Altimmune UK Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

27 Nov 2017  |  Published by:  GlobalData
SummaryAltimmune UK Ltd (Altimmune), formerly Vaxin UK Limited, a subsidiary of Altimmune Inc, is a clinical stage immunotherapeutic biotechnology company that develops synthetic vaccines for mutating viruses. The company designs and develops immunotherapeutic products tailored to address a wide ran...

$ 250.00

Read More

Primary Immune Deficiency (PID) - Pipeline Insight, 2017

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s, “Primary Immune Deficiency (PID)-Pipeline Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across Primary Immune Deficiency (PID). The report provides a complete understanding of the pipeline activities covering all clinical,...

$ 1,250.00

Read More

Primary Immune Deficiency (PID) - Epidemiology Insights to 2025

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s “Primary Immune Deficiency (PID) -Epidemiology Forecast, 2025” provides an overview of the epidemiology trends of Primary Immune Deficiency (PID) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data ...

$ 2,950.00

Read More

Primary Immune Deficiency (PID) - Market Insights, Epidemiology and Market Forecast -2025

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s “Primary Immune Deficiency (PID) - Market Insights, Epidemiology and Market Forecast – 2025” report provides an overview of the disease and in depth research related to Primary Immune Deficiency (PID) for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study peri...

$ 5,750.00

Read More

Primary Immune Deficiency (PID) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s, Primary Immune Deficiency (PID) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017” report provides comprehensive insights about marketed and Phase III products for the Primary Immune Deficiency (PID). The report includes information of marketed products includi...

$ 2,000.00

Read More

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Nov 2017  |  Published by:  DelveInsight
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective o...

$ 2,000.00

Read More
Total 91 records.